GL1X · GenesisL1 explorer

Research workbench

Crystal structure yoph complexed with inhibitor pvs

Analyse Crystal structure yoph complexed with inhibitor pvs in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BLU
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase yoph
EC
3.1.3.48
UniProt
P15273
Ligands
PVS
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase yoph (EC 3.1.3.48)protein28238% helix, 21% strandP15273

Ligands and binding sites

  • PVS · (ethenylsulfonyl)benzene · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12000.520.7822empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3BLU · crystal structure YopH complexed with inhibitor PVS · the same entry in another collection · chain A against A, TM-score 1.00
  • P15273 · AlphaFold monomer V2.0 prediction for tyrosine-protein phosphatase yoph (P15273) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.